期刊文献+

Chitosan Microparticles Intended for Anti-caries DNA Vaccine Mucosal Delivery: Synthesis, Characterization and Transfection

Chitosan Microparticles Intended for Anti-caries DNA Vaccine Mucosal Delivery: Synthesis, Characterization and Transfection
在线阅读 下载PDF
导出
摘要 In order to enhance the mucosal immunity of anti-caries DNA vaccine, chitosan-DNA microparticles for musocal vaccination were prepared by a coacervation method. The physicochemical structure of microparticles was investigated by a scanning electron microscope (SEM) and a cofocal laser scanning microscope (CLSM). For in-vitro studies, Hela cell was transfected by chitosan-DNA microparticles.The expression of proteins was measured by the immunohistochemical methods, and the cytotocity of chitosan in Hela cell line was determined by the MTT assay. The experimental results show that the microparticles are about 2-6 μm in size and spherical in shape. The encapsulation efficiency is 99%, and the DNA is almost captured in the micropraticles. Plasmid loaded into chitosan microparticles is distributed throughout these particles. The number of positive staining cells of chitosan-pGJA-P transfected cell is more than that of naked plasmid transfect cells, but less than that of Lipofect-DNA complex group. Chitosan was found to be less cytotoxic compared with lipofectin (p<0.01). In order to enhance the mucosal immunity of anti-caries DNA vaccine, chitosan-DNA microparticles for musocal vaccination were prepared by a coacervation method. The physicochemical structure of microparticles was investigated by a scanning electron microscope (SEM) and a cofocal laser scanning microscope (CLSM). For in-vitro studies, Hela cell was transfected by chitosan-DNA microparticles.The expression of proteins was measured by the immunohistochemical methods, and the cytotocity of chitosan in Hela cell line was determined by the MTT assay. The experimental results show that the microparticles are about 2-6 μm in size and spherical in shape. The encapsulation efficiency is 99%, and the DNA is almost captured in the micropraticles. Plasmid loaded into chitosan microparticles is distributed throughout these particles. The number of positive staining cells of chitosan-pGJA-P transfected cell is more than that of naked plasmid transfect cells, but less than that of Lipofect-DNA complex group. Chitosan was found to be less cytotoxic compared with lipofectin (p<0.01).
出处 《Journal of Wuhan University of Technology(Materials Science)》 SCIE EI CAS 2005年第2期35-38,共4页 武汉理工大学学报(材料科学英文版)
基金 FundedbytheNationalNaturalScienceFoundationofChina(No.30271416)
关键词 chitosan microparticles anti-caries DNA vaccine TRANSFECTION chitosan microparticles anti-caries DNA vaccine transfection
  • 相关文献

参考文献2

二级参考文献27

  • 1樊明文,郭继华,边专,贾荣,陈智,彭彬,范兵.靶向融合防龋DNA疫苗研究(Ⅰ)-编码人CTLA4胞外区基因的质粒pGCTLA的构建[J].口腔医学研究,2004,20(3):228-228. 被引量:1
  • 2Forester H, Hunter N, Knox KW.Characteristics of a high molecular weight extracellular protein of Streptococcus mutans.J Gen Microbiol, 1983,129:2779-2788.
  • 3Okahashi N, Sassakawa C, Yoshikawa M, et al. Cloning of a surface protein antigengene from serotype c Streptococcus mutans. Mol Microbiol,1989,3:221-228.
  • 4Brandy LJ, Cvitkovitch DG, Geric CM, et al. Delection of the central proline-richrepeat domain results in altered antigenicity and lack of surface expression of theStreptococcus mutans P1 adhesin molecule. Infect Immun, 1998,66:4274-4282.
  • 5Matsushita K, Nisizawa T, Nagaoka S, et al. Identification of antigenic epitopes ina surface protein antigen of Streptococcus mutans in humans. Infect Immun, 1994,62:4034-4042.
  • 6Klavinskis LS, Barnfield C, Gao L, et al. Intranasal immunization with plasmidDNA-Lipoid complexes elicits mucosal immunity in the female genital and rectal tracts. JImmunol,1999,162:254-262.
  • 7Sasaki S, Hamajima K, Fukushima J, et al. Comparison of intranasal andintramuscular immunization against human immunodeficienty virus type 1 with aDNA-monophosphoryl lipid A adjuvant vaccine. Infect Immun, 1998,66:823-826.
  • 8Davis HL,Michel ML, Mancine M, et al.Direct gene transfer in skeletal muscle;plasmid DNA based immunization against the hepatitis B virus surface antigen.Vaccine,1994,12:1503-1509.
  • 9Kuklin N, Daheshia M, Karem K, et al.Induction of mucosal immunity against herpessimplex virus by plasmid DNA immunization. J Virol, 1997,71:31-38.
  • 10Kawabata S, Terao Y, Fujiwara T, et al. Targeted salivary gland immunization withplasmid DNA elicits specific salivary immunoglobulin A and G antibodies and serumimmunoglobulin G antibodies in mice. Infect Immun, 1999,67:5863-5868.

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部